Skip to main content

Table 1 :

From: Prospective evaluation of the impact of potent antiretroviral therapy on the incidence of Kaposi’s Sarcoma in East Africa: findings from the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Consortium

KS Incidence During Non-ART Use and ART Use in East African HIV-infected Adults

 

During Time of No ART Use

During ART Use

CD4+ T cell count (cells/mm3)

No. KS cases

Person-years

Rate

(95% CI)*

No. KS cases

Person-years

Rate

(95% CI)*

0-50

19

645

2943 (1877, 4615)

62

4070

1523 (1187, 1954)

51-100

2

613

326 (81, 1304)

37

5166

716 (518, 988)

101-200

8

1682

475 (237, 951)

45

15651

287 (214, 385)

201-350

27

6383

423 (290, 616)

40

27035

147 (108, 201)

>350

23

13926

165 (109, 248)

31

37804

82 (57, 116)

  1. * per 100,000 person-years